Research output per year
Research output per year
Personal profile
Expertises
Infectious Diseases; Gastroenterology; Hepatology; Microbiology; Virology; Immunology; Flaviviridae; Hepatitis C virus; Molecular Biology
Main research areas
Virology; Vaccine; Antivirals; Immunology; Pathogenesis; Virus Function
Current research
Studies of the life-cycle of viruses, including pathogenesis, host-virus interactions, antivirals and vaccines. Particular focus on hepatitis C virus that causes chronic liver disease resulting in liver cirrhosis and cancer; associated with 750 thousand annual deaths.
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Jens Bukh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals
Offersgaard, A., Duarte Hernandez, C. R., Feng, S., Marichal-Gallardo, P., Holmbeck, K., Pihl, A. F., Fernandez-Antunez, C., Alzua, G. P., Hartmann, K. T., Pham, L. V., Zhou, Y., Gammeltoft, K. A., Fahnøe, U., Schneider, U. V., Pedersen, G. K., Jensen, H. E., Christensen, J. P., Ramirez, S., Bukh, J. & Gottwein, J. M., 17 Feb 2023, In: iScience. 26, 2, p. 105949 105949.Research output: Contribution to journal › Journal article › Research › peer-review
-
Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles
Czarnota, A., Offersgaard, A., Owsianka, A., Alzua, G. P., Bukh, J., Gottwein, J. M., Patel, A. H., Bieńkowska-Szewczyk, K. & Grzyb, K., 31 Jan 2023, (E-pub ahead of print) In: Microbiology spectrum. p. e0254622Research output: Contribution to journal › Journal article › Research › peer-review
-
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
Smit, M. J., Sander, A. F., Ariaans, M. B. P. A., Fougeroux, C., Heinzel, C., Fendel, R., Esen, M., Kremsner, P. G., Ter Heine, R., Wertheim, H. F., Idorn, M., Paludan, S. R., Underwood, A. P., Binderup, A., Ramirez, S., Bukh, J., Soegaard, M., Erdogan, S. M., Gustavsson, T., Clemmensen, S., & 8 others, Mar 2023, In: The Lancet. Microbe. 4, 3, p. e140-e148Research output: Contribution to journal › Journal article › Research › peer-review
-
Identification of novel neutralizing determinants for protection against HCV
Alzua, G. P., Pihl, A. F., Offersgaard, A., Velázquez-Moctezuma, R., Hernandez, C. R. D., Augestad, E. H., Fahnøe, U., Mathiesen, C. K., Krarup, H., Law, M., Prentoe, J., Bukh, J. & Gottwein, J. M., 1 Mar 2023, In: Hepatology (Baltimore, Md.). 77, 3, p. 982-996 15 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection
Fossat, N., Lundsgaard, E. A., Costa, R., Rivera-Rangel, L. R., Nielsen, L., Mikkelsen, L. S., Ramirez, S., Bukh, J. & Scheel, T. K. H., 9 Mar 2023, (E-pub ahead of print) In: Cell reports. 42, 4, p. 112282Research output: Contribution to journal › Journal article › Research › peer-review